(Press-News.org) How fat is distributed in people’s bodies could make a difference to their risk of certain cancers, according to new research led by the University of Bristol. The international study is published in the Journal of the National Cancer Institute (JNCI) today [24 September].
Scientists have already shown that having obesity increases a person’s risk of developing certain cancers. Obesity is usually measured using body mass index (BMI), but growing evidence – particularly from heart health research – suggests that BMI alone doesn't capture the full picture when it comes to obesity-related health risks. However, the role of fat distribution in cancer risk has been relatively unexplored.
Researchers in Bristol’s Integrative Cancer Epidemiology Programme (ICEP) investigated whether body fat at different locations across the body influences the risks of 12 obesity-related cancers - endometrial, ovarian, breast, colorectal, pancreas, multiple myeloma, liver, kidney (renal cell), thyroid, gallbladder, oesophageal adenocarcinoma, and meningioma.
They used a technique known as Mendelian randomisation, which uses statistics, computing and the natural variations in people’s genetics to identify patterns in large health data sets.
The team found that fat distribution appears to influence cancer risk – but the relationship varies by cancer type. For some cancers, where fat is stored in the body seems more important than how much is stored; for others, the reverse is true; and, for some, both matter. In cancers where distribution is important, the specific locations of body fat driving this seem to differ by cancer, meaning the overall picture is quite complex.
Lead author, Dr Emma Hazelwood, who recently completed her PhD at the University of Bristol, explained: “These findings support the growing consensus that BMI, while useful for population-level trends, may be too simplistic for assessing individual health risks.
“Our results tell us that there is no ‘one-size-fits-all’ when it comes to cancer, meaning a more tailored approach to cancer prevention in people with obesity could be most effective."
The paper’s findings fit with recent calls for change, including the 2024 European Association for the Study of Obesity framework and the Lancet Commission on the future of obesity, which have emphasised that BMI is a flawed diagnostic tool and that fat distribution matters.
In the future, a better understanding of how fat distribution across the body affects cancer risk could help identify those most at risk and guide more personalised approaches to obesity treatment and cancer prevention.
The research team recommend further work is needed, using different approaches and studying non-European populations.
Dr Hazelwood added: “It is vital to understand the biological mechanisms that underpin these associations – particularly how and why different fat depots affect cancer development. In the longer term, we need to explore how obesity treatments – whether lifestyle or drug-based – influence these risk pathways.”
Dr Julia Panina, Head of Research Funding at World Cancer Research Fund, added: “Our evidence-based Cancer Prevention Recommendations highlight the role of maintaining a healthy weight to reduce cancer risk. While this remains essential, growing scientific evidence shows that body composition - particularly how fat is distributed throughout the body - is also a crucial factor.
“With support from our fantastic donors, we were able to co-fund the University of Bristol’s excellent team whose findings will help direct this exciting area towards possible new cancer prevention and treatments.”
This study was funded by the World Cancer Research Fund (WCRF UK) and Cancer Research UK (Integrative Cancer Epidemiology Programme). This work was carried out at the MRC Integrative Epidemiology Unit (MRC IEU), which is supported by the Medical Research Council (MRC) and the University of Bristol.
END
Distribution of fat could influence cancer risk, study suggests
2025-09-24
ELSE PRESS RELEASES FROM THIS DATE:
Screening approach enhances CRISPR genome-editing efficiency
2025-09-23
(MEMPHIS, Tenn. – September 23, 2025) Natural systems such as CRISPR-associated transposons (CASTs) offer a targetable, one-step way to edit genomes. However, adapting them for biomedical applications has been challenging. To address this limitation, scientists at St. Jude Children’s Research Hospital designed a screening approach to measure efficiency and specificity for thousands of CAST variants accurately. This high-throughput approach allowed the researchers to rapidly optimize promising candidate ...
Drinking any amount of alcohol likely increases dementia risk
2025-09-23
Drinking any amount of alcohol likely increases the risk of dementia, suggests the largest combined observational and genetic study to date, published online in BMJ Evidence Based Medicine.
Even light drinking—generally thought to be protective, based on observational studies—is unlikely to lower the risk, which rises in tandem with the quantity of alcohol consumed, the research indicates.
Current thinking suggests that there might be an ‘optimal dose’ of alcohol for brain health, but most of these studies have focused on older people and/or didn’t differentiate between former and lifelong non-drinkers, complicating efforts ...
BMJ Group retracts trial on apple cider vinegar and weight loss
2025-09-23
BMJ Group has retracted research suggesting that small daily quantities of apple cider vinegar might help people who are overweight or obese to lose weight.
The small clinical trial was published in the open access journal BMJ Nutrition, Prevention & Health in March 2024 and its findings press released. The study findings generated widespread international attention at the time, and continue to be frequently referred to in media coverage.
The retraction was prompted by concerns raised about the quality of the work, ...
Significant rise in use of low/alcohol-free drinks among ‘risky’ UK drinkers in past 5 years
2025-09-23
There’s been a significant rise in the use of low and alcohol-free drinks to curb alcohol intake among ‘risky drinkers’ over the past 5 years in England, Wales, and Scotland, finds research published in the open access journal BMJ Public Health.
The proportion of those using them to make serious attempts to cut down their alcohol intake rose from 35% in 2020 to 44% in 2024, while those using them in any attempt to cut down increased from 26% to 39%.
The trends were especially noticeable ...
Regular exercise ‘rewires’ heart-control nerves differently on left and right side, study finds
2025-09-23
Frequent exercise doesn’t just strengthen the heart – it also changes the nerves that control it, according to new research which could guide more targeted and effective care for common heart problems.
The study, led by the University of Bristol (UK), shows for the first time that moderate aerobic training reshapes nerves that drive the heart, and affects them on each side of the heart differently. The research is published in the journal Autonomic Neuroscience today (Wednesday, 24 September).
Findings ...
Centenary of the birth of IVF pioneer Sir Robert Edwards
2025-09-23
Saturday 27th September marks the centenary of the birth of Sir Robert Edwards, who with colleagues Patrick Steptoe and Jean Purdy oversaw the conception and birth of the world’s first IVF baby in 1978.(1) It was a breakthrough in reproductive medicine which would bring immeasurable benefits to people with infertility and whose demographic importance today is greater than ever.
Now, from various reports published by this journal, we can confidently say that the global impact of IVF continues to grow in terms of children conceived and the extent of its use. There are few causes of infertility which today are not amenable to treatment while ...
New multi-registry study highlights ocrelizumab’s superior relapse control in multiple sclerosis
2025-09-23
(Barcelona, Spain, Wednesday, 24 September 2025) New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) demonstrates that ocrelizumab provides superior control of multiple sclerosis (MS) relapses compared with fingolimod, natalizumab, and alemtuzumab.1
Ocrelizumab, a monoclonal antibody targeting CD20+ B cells, was evaluated using real-world data from three large MS registries: MSBase, OFSEP, and the Danish MS Registry. The analysis compared ocrelizumab-treated patients ...
Wonhwa Cho to receive Biophysical Society’s 2026 Award in the Biophysics of Health and Disease
2025-09-23
BETHESDA, MD – The Biophysical Society is pleased to announce that Wonhwa Cho, of the University of Illinois Chicago, USA, has been named the recipient of the 2026 BPS Award in the Biophysics of Health and Disease. Cho will be honored at the Society’s 70th Annual Meeting, being held in San Francisco, California from February 21-25, 2026.
Cho will be recognized for mechanistic elucidation of lipid-protein interactions foundational to lipid-targeted drug discovery.
“Wonhwa has pioneered new and innovative experimental approaches to overcome obstacles ...
Future generations: NSF-funded project explores how nanoplastics are transmitted to offspring
2025-09-23
You can’t see nanoplastics with the naked eye, but they’re everywhere — including your body.
Tinier than the better-known microplastics, these plastic particles range from one nanometer to one micrometer in size; a human hair, by comparison, is about 100 micrometers thick.
“Nanoplastics are present in drinking water, food and the air, and have been detected in both tap water and bottled water,” explained Binghamton University Assistant Professor of Chemistry Huiyuan Guo. “They are widely detected in the environment.”
Guo and Associate Professor of Biological Sciences ...
Erdinc Sezgin to receive 2026 Early Independent Career Award
2025-09-23
BETHESDA, MD – The Biophysical Society is pleased to announce that Erdinc Sezgin, of SciLifeLab, Karolinska Institutet, Sweden, has been named the recipient of the 2026 Early Independent Career Award. Sezgin will be honored at the Society’s 70th Annual Meeting, being held in San Francisco, California from February 21-25, 2026.
Sezgin will be recognized for combining chemistry, physics, biology and computer science to gain fundamental and translational insights into how the biophysics of cells affect health and disease.
“I am delighted that Erdinc ...